Literature DB >> 7252669

Arthropathy with rash, chronic meningitis, eye lesions, and mental retardation.

A M Prieur, C Griscelli.   

Abstract

Three unrelated children (one girl and two boys) have had since birth a syndrome characterized by a permanent skin rash which becomes more intense during flare-ups associated with fever, lymphadenopathy, splenomegaly, and arthritis symmetrically involving the large joints. In one boy, typical psoriasis was observed at age 3 years. In two patients, roentgenograms of the joints showed early patellar ossification and an abnormal epiphyseal appearance. The three children also had neurologic involvement, with mental retardation, enlarged head circumference, eye lesions, late closure of the anterior fontanel, and a chronic meningitis with infiltration by polymorphonuclear cells. No immunologic abnormalities were found, but polymorphonuclear cells infiltrated the skin, lymph nodes, synovial fluid, and CSF.

Entities:  

Mesh:

Year:  1981        PMID: 7252669     DOI: 10.1016/s0022-3476(81)80961-4

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  28 in total

Review 1.  Inflammasome-mediated autoinflammatory disorders.

Authors:  Shruti P Wilson; Suzanne L Cassel
Journal:  Postgrad Med       Date:  2010-09       Impact factor: 3.840

2.  Post-inflammatory retinal dystrophy in CINCA syndrome.

Authors:  Donato Rigante; Achille Stabile; Angelo Minnella; Laura Avallone; Lucia Ziccardi; Giulia Bersani; Giovanna Stifano; Adele Compagnone; Benedetto Falsini
Journal:  Rheumatol Int       Date:  2009-05-08       Impact factor: 2.631

Review 3.  [Genetics of cryopyrin-associated periodic syndrome].

Authors:  J B Kümmerle-Deschner; P Lohse
Journal:  Z Rheumatol       Date:  2017-05       Impact factor: 1.372

4.  De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases.

Authors:  Ivona Aksentijevich; Miroslawa Nowak; Mustapha Mallah; Jae Jin Chae; Wendy T Watford; Sigrun R Hofmann; Leonard Stein; Ricardo Russo; Donald Goldsmith; Peter Dent; Helene F Rosenberg; Frances Austin; Elaine F Remmers; James E Balow; Sergio Rosenzweig; Hirsh Komarow; Nitza G Shoham; Geryl Wood; Janet Jones; Nadira Mangra; Hector Carrero; Barbara S Adams; Terry L Moore; Kenneth Schikler; Hal Hoffman; Daniel J Lovell; Robert Lipnick; Karyl Barron; John J O'Shea; Daniel L Kastner; Raphaela Goldbach-Mansky
Journal:  Arthritis Rheum       Date:  2002-12

Review 5.  Autoinflammation: the prominent role of IL-1 in monogenic autoinflammatory diseases and implications for common illnesses.

Authors:  Raphaela Goldbach-Mansky; Daniel L Kastner
Journal:  J Allergy Clin Immunol       Date:  2009-12       Impact factor: 10.793

6.  Effect of anakinra on arthropathy in CINCA/NOMID syndrome.

Authors:  Takako Miyamae; Yutaka Inaba; Gen Nishimura; Masako Kikuchi; Takayuki Kishi; Ryoki Hara; Utako Kaneko; Toshihiko Shinoki; Tomoyuki Imagawa; Shumpei Yokokta
Journal:  Pediatr Rheumatol Online J       Date:  2010-03-16       Impact factor: 3.054

7.  Critical appraisal of canakinumab in the treatment of adults and children with cryopyrin-associated periodic syndrome (CAPS).

Authors:  Ori Toker; Philip J Hashkes
Journal:  Biologics       Date:  2010-05-25

Review 8.  Monogenic autoinflammatory diseases: concept and clinical manifestations.

Authors:  Adriana Almeida de Jesus; Raphaela Goldbach-Mansky
Journal:  Clin Immunol       Date:  2013-04-09       Impact factor: 3.969

Review 9.  Autoinflammatory diseases: mimics of autoimmunity or part of its spectrum? Case presentation.

Authors:  Maria Helena B Kiss; Claudia Saad Magalhães
Journal:  J Clin Immunol       Date:  2008-03-20       Impact factor: 8.317

10.  An autoinflammatory disease due to homozygous deletion of the IL1RN locus.

Authors:  Sreelatha Reddy; Shuang Jia; Rhonda Geoffrey; Rachel Lorier; Mariko Suchi; Ulrich Broeckel; Martin J Hessner; James Verbsky
Journal:  N Engl J Med       Date:  2009-06-04       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.